domingo, 1 de febrero de 2026

RFK, Jr.’s Children Health Defense files racketeering suit against American Academy of Pediatrics claiming it endorses vaccines because it’s on-the-take from drug makers Walker Bragman | Important Context | January 30, 2026

https://geneticliteracyproject.org/2026/01/30/rfk-jr-s-children-health-defense-files-racketeering-suit-against-american-academy-of-pediatrics-claiming-it-endorses-vaccines-because-its-on-the-take-from-drug-makers/

Optimizing Management of NF1-Associated Plexiform Neurofibromas: Expert Multidisciplinary Team Discussions Authors: Judith Eelloo, RGN, RSCN, MPhil; Darren Hargrave, MD; Zhichao Wang, MD, MPH; Kaleb Yohay, MD

https://www.medscape.org/viewarticle/optimizing-management-nf1-associated-plexiform-neurofibromas-2025a1000rv5?page=1&sso=true&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260131-12077439-ES_LANG-HONC#expert-commentary-es

Real-Time Insights Into the Diagnosis and Management of ATTR: From Genetic Insight to Therapeutic Innovation Authors: Kevin M. Alexander, MD; Marianna Fontana, MD, PhD; Ronald Witteles, MD

https://www.medscape.org/viewarticle/real-time-insights-diagnosis-and-management-attr-genetic-2025a1000yeo?page=1&sso=true&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260131-12121766-ES_LANG-NEUR#transcript-download-es

Addressing Challenges for Patients With HR+/HER2- EBC: Managing AEs and Optimizing Adherence Authors: Sarah Donahue, MPH, NP, AOCNP; Erika Hamilton, MD; Nadia Harbeck, MD, PhD

https://www.medscape.org/viewarticle/1002936?sso=true&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260131-OUS-HONC-1002936-cta

Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies Authors: Manali Bhave, MD; Nadia Harbeck, MD, PhD

https://www.medscape.org/viewarticle/patients-progressing-ai-cdk4-6-inhibitors-biomarkers-2025a1000wtp?page=1&sso=true&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260131-OUS-HONC-patients-progressing-ai-cdk4-6-inhibitors-biomarkers-2025a1000wtp-cta

Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC Authors: Solange Peters, MD, PhD; Shirish M. Gadgeel, MD; Rafal Dziadziuszko, MD, PhD

https://www.medscape.org/viewarticle/conference-insights-breaking-developments-alk-positive-nsclc-2025a1000vwn?page=1&sso=true&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260201-OUS-HONC-conference-insights-breaking-developments-alk-positive-nsclc-2025a1000vwn-cta

Which breast cancer subtype showed the best response to boost radiation in P-RAD (Medscape AI)

https://www.medscape.com/ai-search?query=Which%20breast%20cancer%20subtype%20showed%20the%20best%20response%20to%20boost%20radiation%20in%20P-RAD&ecd=mkm_ret_260201_mscpmrk_onc_breast-cancer_etid8067747&uac=148436CN&impID=8067747